3-Substituted benzylidene-1,3-dihydro-indoline derivatives were tested for their in vitro antibacterial activity against the Gram-negative bacteria Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and the Gram-positive bacteria Bacillus subtilis, Staphylococcus aureus, and for their their in vitro antifungal activity against Candida krusei and Candida albicans. The minimum inhibitory concentration (MIC) values were determined by the 2-fold serial dilution technique in Mueller Hinton broth and Sabouraud dextrose agar using antibacterial and antifungal assays, respectively. For comparison of the antimicrobial activity, rifampicin, ampicillin trihydrate, gentamicin sulfate, and ofl oxacin were used as reference antibacterial agents, and fl uconazole and amphotericin B were employed as reference antifungal agents. The most active compound 10 showed notable inhibition against Bacillus subtilis, Staphylococcus aureus, and Candida krusei. Compounds 1 and 6 were found slightly effective against Klebsiella pneumoniae and Escherichia coli. In addition, compounds 13 and 14 showed inhibition against Bacillus subtilis and Staphylococcus aureus. Indole derivatives were also tested in vitro for replication of the HepAD38 cell line and compared with lamivudine (3TC, L-2′,3′-dideoxy-3′-thiacytidine). The IC 50 values of the compounds were found to be >1000 μM against HBV except for compound 13 which exhibited activity with an IC 50 value of 500 μM.
Introduction
Heterocyclic indole compounds represent several important classes of compounds with biological activities. The most important of these are anti-infl ammatory, anticonvulsant, antidepressant, antihistamine, antitubercular, antidiabetic, anthelmintic, antiallergic, antiviral, antibacterial, and antifungal activities. In several studies indole derivatives have been found to be associated with antimicrobial and antifungal activities. Among them, haloindoles, ethyl-3-indolylacrylate, 5-bromo-3-(2-cyanovinyl)indole and 3-(2-nitrovinyl) indole (Whitehead and Whitesitt, 1974) , 3-acyl-4,7-dihydroxy indoles (Malesani et al., 1974) , 1-(4-phenyl)-and (1-naphthyl-4H-1,2,4-tria zole-5-thion-3-yl)indoles (Tsotinis et al., 1997) , some indole-containing derivatives of thio semicarbazide and their cyclic 1,2,4-triazole and 1,3,4-thiadiazole analogues (Varvaresou et al., 2000) , several indole derivatives fused with heterocyclic compounds such as 4H-pyrano[2,3-f]-indole, benzotetrahydrocyclohept [1,2-b] indole, and 1-triazolylethylbenz[g]indole (Macchia et al., 1996; Gadaginamath and Kavali, 1999; Bhovi and Gadaginamath, 2005) , and 1-morpholino-3-carbethoxy-5-hydroxy-2-methylindole (Donawade and Gadaginamath, 2005) were found to be active against a large number of microorganisms. More recently, 38 indole carboxamide and propanamide compounds were screened for their antimicrobial, antifungal and antiviral activities and some of them were found to be active against Candida albicans (Ölgen et al., 2008) .
Several indole dione and indole-2-one derivatives were also investigated as antimicrobial and antifungal agents. Isatin N-Mannich bases were tested for their antiviral, antimicrobial and antifungal activities and some of them were found to be highly active (Varma et al., 1975) . A study on isatin derivatives showed that substituted isatin-beta-thiosemicarbazones and isatin-betahydrazonothiazoline derivatives have potent anti microbial and antiviral activities (Omar et al., 1984) . Another study also showed that some organotin(IV) complexes with isatin and N-alkylisatin bisthiocarbonohydrazones exhibit good antibacterial activity (Bacchi et al., 2005) .
Variously substituted indole-2,3-dione hydrazone derivatives were tested for their antimicrobial activities especially towards Salmonella typhi, Streptococcus beta haemoliticus, Mycobacterium paratuberculosis 607, Aspergillus niger, Candida albicans, and Saccharomyces cerevisiae (Piscopo et al., 1986a (Piscopo et al., , b, 1987 . 1-Substituted aminomethyl-3-cyclohexylthiosemicarbazone-2-indolinones were tested against several microorganisms and fungi, and the majority of the compounds exhibited promising antibacterial and antifungal activities (Singh and Jha, 1989) . Benzylideneindolone derivatives showed potent antimicrobial activity against Staphylococcus aureus in μM ranges (Angell et al., 2004) (Abdel-Rahman et al., 2004) . Among the potent diorganosilicon(IV) complexes of indole-2,3-dione derivatives it was shown that diphenylsilicon complexes of 1,3-dihydro-3-[2(4-nitrophenyl)-2-oxoethylidene]-2H-indole-2-one-hydrazinecarbothioamide demonstrate potent antifungal and antibacterial activities (Singh and Nagpal, 2005) . In addition, 1H-indole-4,7-diones were reported as potent inhibitors of Candida krusei, Cryptococcus neoformans, and Aspergillus niger (Ryu et al., 2007) .
Several indole derivatives were also studied for their antiviral activities. Among them, 5-chloro-3-(phenylsulfonyl)indole-2-carboxamide derivatives were found to be HIV-1 reverse transcriptase inhibitors with IC 50 values in the nM range (Williams et al., 1993 ). An indole-containing compound, delavirdine (Fig. 1) , was shown to be a HIV-1 reverse transcriptase inhibitor and approved as a commercial anti-HIV drug named, Rescriptor ® (Romero et al., 1996) . N-Alkyl-substituted indolocarbazoles were reported to be potent inhibitors of the human cytomegalovirus in nM concentrations (Slater et al., 2001) . A study showed that ethyl-6-bromo-5-hydroxy-1H-indole-3-carboxylate derivatives are potent infl uenza virus inhibitors (Zhao et al., 2004) . Some tetracyclic indole derivatives were reported as HCV inhibitors with IC 50 values less than 5 μM (Conte et al., 2006) . Recently, N-morpholinoacetyl-2-phenyl-indole-6-carboxylic acid was determined as a potent inhibitor of subgenomic hepatitis C virus replication with an IC 50 value of 0.127 μM (Harper et al., 2005) . A structurally similar compound, Nmethyl-2-phenyl-3-cyclohexyl-indole-6-carboxylic acid was reported by another research group to be an allosteric inhibitor of the HCV virus with an IC 50 value of 0.009 μM (Beaulieu et al., 2006) . Oxindole derivatives were also investigated as antiviral agents and some of them were found to be potent HIV-1 non-nucleoside reverse transcriptase inhibitors (Jiang et al., 2006) . Prompted by these fi ndings about antimicrobial and antiviral activities of several indolinone derivatives, we investigated herein the antimicrobial, antifungal and antiviral activities of 3-substituted benzylidene-1,3-dihydro-indoline-2-one deri vatives and their modifi ed congeners 3-substituted benzylidene-1,3-dihydro-indoline-2-thione ( Fig. 2 ) which were previously evaluated as tyrosine and protein kinase inhibitors (Olgen et al., 2005 (Olgen et al., , 2007 . bicans ATCC 10231, Candida krusei ATCC 6258 were used.
Experimental

Materials
Antimicrobial activity
Tests of standard strains of Klebsiella pneumoniae RSHM 574, Pseudomonas aeruginosa ATCC 25853, Escherichia coli ATCC 25922, Bacillus subtilis ATCC 6633, Staphylococcus aureus ATCC 25923, Candida albicans ATCC 10231, Candida krusei 6258 and clinical isolates of these microorganisms that are known to be resistant to various antimicrobial agents were included in the study. The resistance of the clinical isolates was determined by the Kirby Bauer disk diffusion method according to the guidelines of Clinical and Laboratory Standards Institute (CLSI) (2006a). Standard powders of rifampicin, ampicillin trihydrate, gentamicin sulfate, ofl oxacin, fl uconazole, and amphotericin B were obtained from the manufacturers. Stock solutions were prepared in DMSO for ofl oxacin, in methanol for rifampicin, in phosphate-buffered saline (PBS), pH 8, for ampicillin trihydrate, and distilled water for gentamicin sulfate, fl uconazole, and amphotericin B. All bacterial isolates were sub-cultured in MHA plates and incubated overnight at 37 ºC. All Candida isolates were sub-cultured in SDA plates at 35 ºC for 24 -48 h. The microorganisms were passaged at least twice to ensure purity and viability. The solutions of the newly synthesized compounds and standard drugs were prepared at concentrations of 1000, 500, 250, 125, 62.5, 31.25, 15.63, 7.8, 3.9, 1.95, 0.98, 0.48, 0.24, 0.12, 0 .06 μg/ ml in the wells of microplates by diluting in the liquid media. Bacterial susceptibility testing was performed according to the guidelines M100-S16 of Clinical and Laboratory Standards Institute (CLSI) (2006b). The bacterial suspensions used for inoculation were prepared at 10 5 cfu/ml by diluting fresh cultures at MacFarland 0.5 density (10 7 cfu/ml) (McFarland, 1907) . Suspensions of the bacteria at 10 5 cfu/ml were inoculated to a 2-fold diluted solution of the compounds. The bacteria amount was found to be 10 4 cfu/ml in the wells after inoculations. MHB was used for diluting the bacterial suspensions and for 2-fold dilution of the compounds. DMSO, water, PBS, pure microorganisms, and pure media were used as controls. A 10-μl bacteria inoculum was added to each well of the microdilution trays. The trays were incubated at 37 ºC in a humid chamber, and MIC endpoints were read after 24 h of incubation. All organisms were tested in triplicate in each run of the experiments. The lowest concentration of the compounds that completely inhibited the the macroscopic growth was determined and minimum inhibitory concentrations (MICs) were reported.
All Candida isolates were sub-cultured in SDA plates, incubated at 35 °C for 24 -48 h prior to antifungal susceptibility testing, and passaged at least twice to ensure purity and viability. Susceptibility testing was performed in RPMI-1640 medium, buffered with L-glutamine, pH 7, and MOPS, and culture suspensions were prepared according to the guideline CLSI M27-A of Clinical and Laboratory Standards Institute (2006c). The yeast suspensions used for inoculation were prepared at 10 4 cfu/ml by diluting fresh cultures at McFarland 0.5 density (10 6 cfu/ml) (McFarland, 1907) . Suspensions of the yeast at 10 4 cfu/ml were inoculated to a 2-fold diluted solution of the compounds. The yeast amount was found to be 10 3 cfu/ ml in the wells after inoculations. A 10-μl yeast inoculum was added to each well of the microdilution trays. The trays were incubated at 35 ºC in a humid chamber, and MIC endpoints were read after 48 h of incubation. All organisms were tested in triplicate in each run of the experiments. The lowest concentration of the compounds that completely inhibited the macroscopic growth was determined and MIC values were reported.
Antiviral activity
The in vitro replication ability of the HepAD38 cell line (was kindly gifted by Raymond F. Schinazi, Emory University, Atlanta, USA) was tested in the presence of the novel compounds synthesized. 24-Well plates were seeded with 5 · 10 4 HepAD38 cells in growth medium containing DMEM/Ham's F12 supplemented with 10% (v/v) heat-inactivated fetal calf serum, 100 IU/ml penicillin/50 μg/ml streptomycin mix, 400 μg/ml G418, and 0.3 μg/ml tetracycline. In order to initiate viral replication, the growth medium was changed with the assay medium by the withdrawal of tetracycline. 2 d post seeding, the cells were fed with fresh assay medium alone to test the replication effi ciency or with assay medium containing increasing concentrations (0.1, 1, 10 and 100 μM) of the compounds. The supernatant of the cells fed with only fresh assay medium was collected every day during 5 d and the supernatant of the cells fed with the drug-containing assay medium was collected at the end of the fi fth day. Viral DNA extraction was performed using "QIAamp DNA Mini Kit" (Qiagen, Basel, Switzerland) according to the manufacturer's instructions. The HBV activity of the compounds was measured with a realtime PCR method using hybridization probes and "Fast Start DNA Hybridization Kit" (Roche Diagnostics, Indianapolis, USA). Two independent experiments were performed for each drug and the results compared with those of lamivudine.
Results and Discussion
The in vitro antibacterial activities of all synthesized compounds were assayed against the The compounds were also evaluated for their antifungal activity against Candida albicans ATCC 10231, Candida krusei ATCC 6258 and Candida albicans isolate. The MIC values were calculated by the 2-fold serial dilution technique in MHB and SDA for the antibacterial and antifungal assay, respectively. For comparison of the antimicrobial activity, rifampicin, ampicillin trihydrate, gentamicin sulfate, and ofl oxacin were used as the reference antibacterial agents, and fl uconazole and amphotericin B were used as the reference antifungal agents. The MIC values of the compounds are given in μg/ml in Table I .
The most active compound, 3-(3′-fl uorobenzylidene)-1,3-dihydro-indoline-2-thione (10), showed notable inhibition (15.62 -62.5 μg/ml) against Bacillus subtilis, Staphylococcus aureus, and Candida krusei. Although 10 showed the largest activity spectrum, inhibited Gram-positive bacteria and fungi, its oxo congener 3 did not exhibit the similar antimicrobial spectrum. Compounds 1 and 6 were found slightly effective against the Gram-negative bacteria Klebsiella pneumoniae and Escherichia coli with MIC values between 31.5 to 62.5 μg/ml. In addition, the antibacte- Table I . MIC values of indole derivatives (in μg/ml). 125  250  250  250  250  62.5  125  62.5  250  250  125  125  250  2  250  500  500  500  500  125  250  125  500  500  250  250  250  3  250  500  500  500  500  125  250  125  500  500  250  500  500  4  250  500  500  500  500  125  250  125  500  500  250  500  500  5  250  500  500  500  500  125  250  125  500  500  250  250  250  6  250  500  500  500  500  62.5  250 31.25 500  500  250  250  250  7  250  500  500  500  500  125  250  125  500  500  250  250  250  8  250  500  500  500  250  125  250  125  500  500  250  250  250  9  125  250  250  125  125  125  250  125  125  125  125  125 There is no certain relationship between the structure and activity of the compounds. Although the most active compound 10 has lipophilic fl uoro substitution on the benzene ring at position 3 of the indole scaffold, the other active compounds have polar substituents such as N(CH 3 ) 2 , OH and OCH 3 . However, the other halogen-substituted compounds 3-(3′,4′-dichloro-benzylidene)-1,3-dihydro-indoline-2-thione (9) and 3-(2′-chloro-5′-nitro-benzylidene)-1,3-dihydro-indoline-2-thione (11) slightly inhibited Candida krusei and Klebsiella pneumoniae, respectively. These results showed that no direct evidence between the antimicrobial activity and lipophilicity of the tested compounds is found. Perhaps the reason for activity differences is that the geometric orientation of the isomers (Z-or E-) causes diverse activity patterns. An attempt to generalize the relation of activity to the chemical structure of the compounds leads to the following conclusions: the small structural differences result in great differences of the antimicrobial activity, and the same substitution pattern on indole-2-one and -2-thione may cause diverse inhibition profi les of microorganisms including the type of microorganisms. Based on the present study, 10 might be of interest for designing indole-2-thione derivatives as a new hit for compounds with antimicrobial activity. Variously substituted hydrazone indole-2,3-dione derivatives were studied by Piscopo et al. (1987) and they reported that bromo-substituted aromatic ringcontaining compounds were found to be the most active against microorganisms. Our next goal is to investigate the role of halogen atoms attached at different positions of the aromatic ring of oxindole and thioindole derivatives for the evaluation of antimicrobial activity. Moreover, our future design of antimicrobial agents should be also orientated towards further hydrophilic and lipophilic analogues of indole-2-one and -2-thione to clarify the effects of physicochemical properties on the antimicrobial activity. Keeping the favourable substituted aromatic ring at position 3 as well as the substitution on the indole nucleus, especially fi ve positions will be investigated.
Since some indole-2-one derivatives presented potent antiviral activity and it was important to test our compounds for their potential as anti-HBV drugs, the HBV activity of the compounds was measured with a real-time PCR method using hybridization probes and "Fast Start DNA Hybridization Kit" according to a previously published protocol (Bozkaya et al., 2005) . Two independent experiments were performed for each drug and the anti-HBV activity of lamivudine (Borgia and Gentile, 2006) (Fig. 1) was used as the positive control. The IC 50 values of the compounds were found >1000 μM against HBV, except 13 [3-(3′-hydroxy-4′-methoxy-benzylidene)-1,3-di hydro-indoline-2-thione] which showed activity with an IC 50 value of 500 μM. The IC 50 value of lamivudine was detected as 0.29 μM at the same reaction conditions. Some results from literature show that more ionized compounds or compounds containing the H-bond-donating groups such as NH 2 , COO -and CH 2 OH containing compounds are better inhibitors of the HBV virus (Beaulieu et al., 2006; Thakur et al., 2006) . The introduction of these types of functional groups on the indole unit might lead to the discovery of unexploited interactions with the protein and further improvements of the overall potency. Polar substituents might be also favourable for 3-substituted benzylidene-1,3-dihydro-indoline-2-one and -2-thione derivatives to develop new antiviral agents. Our future aim to design new antiviral indole derivatives will be based on searching the effects of both lipophilic and hydrophilic substituents for antiviral activities.
